ITB650 Attachment 5 - Cost Matrix Summary

ITB650 Attachment 5 is a cost matrix document supporting Idaho's procurement for antitubercular medications. The state of Idaho is seeking proposals for multiple medications needed to combat tuberculosis, with proposals due by February 24, 2025. The procurement timeline allows potential vendors approximately seven weeks from the January 3, 2025 posting date to prepare and submit comprehensive responses. The contract is structured to accommodate multiple vendors, potentially allowing for tiered or segmented contract awards based on medication types and quantities. Specific details regarding site visits, bidder's meetings, award dates, and contract term including renewal options are not provided in this cost matrix attachment.

The cost matrix document serves as a pricing and evaluation tool for the bidding process. Pharmaceutical contracts for state-level tuberculosis treatment programs typically range from several hundred thousand to multiple million dollars annually, depending on population needs and medication complexity. The procurement follows standard Idaho state procurement guidelines and does not specify explicit set-aside designations in the documentation reviewed. Bidders must demonstrate extensive pharmaceutical expertise, including detailed documentation of medication efficacy, manufacturing capabilities, quality control processes, and compliance with federal and state healthcare regulations. Vendors must demonstrate proven track records in producing high-quality antitubercular medications with emphasis on product reliability, dosage consistency, and capability for large-scale distribution across Idaho's healthcare system.